Xiong Tian

Linhai, 317000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Epigenetic inactivation of COL4A4 orchestrates JAK2/STAT3-driven progression and microenvironment reprogramming in renal cell carcinoma.

Epigenetic inactivation of COL4A4 orchestrates JAK2/STAT3-driven progression and microenvironment reprogramming in renal cell carcinoma.

Journal: International immunopharmacology

Published: June 12, 2026

DCST1-AS1 promotes renal cell carcinoma progression via regulating the miR-582-5p/HMGB2 axis.

DCST1-AS1 promotes renal cell carcinoma progression via regulating the miR-582-5p/HMGB2 axis.

Journal: Journal of translational medicine

Published: July 16, 2025

Integrated single-cell, spatial, and bulk transcriptomics reveal a chromatin regulator-TME prognostic framework guiding precision therapy in cervical cancer.

Integrated single-cell, spatial, and bulk transcriptomics reveal a chromatin regulator-TME prognostic framework guiding precision therapy in cervical cancer.

Journal: Journal of translational medicine

Published: April 03, 2025

SMAD4-armed oncolytic adenovirus therapy potentiates the chemotherapy effects in NSCLC through suppression of the Wnt/β-catenin pathway.

SMAD4-armed oncolytic adenovirus therapy potentiates the chemotherapy effects in NSCLC through suppression of the Wnt/β-catenin pathway.

Journal: Cancer gene therapy

Published: April 01, 2025

SNRPB2: a prognostic biomarker and oncogenic driver in esophageal cancer via β-catenin/c-Myc signaling.

SNRPB2: a prognostic biomarker and oncogenic driver in esophageal cancer via β-catenin/c-Myc signaling.

Journal: Frontiers in oncology

Published: November 29, 2024

Functional evaluation of novel compound heterozygous variants in SLC12A3 of Gitelman syndrome.

Functional evaluation of novel compound heterozygous variants in SLC12A3 of Gitelman syndrome.

Journal: Orphanet journal of rare diseases

Published: October 16, 2024

Label-free analysis of the β-hydroxybutyricacid drug on mitochondrial redox states repairment in type 2 diabetic mice by resonance raman scattering.

Label-free analysis of the β-hydroxybutyricacid drug on mitochondrial redox states repairment in type 2 diabetic mice by resonance raman scattering.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 23, 2023

LINC01614 is a promising diagnostic and prognostic marker in HNSC linked to the tumor microenvironment and oncogenic function.

LINC01614 is a promising diagnostic and prognostic marker in HNSC linked to the tumor microenvironment and oncogenic function.

Journal: Frontiers in genetics

Published: November 13, 2023

Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma.

Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma.

Journal: Frontiers in pharmacology

Published: May 09, 2022

A Family Segregating Lethal Primary Coenzyme Q10 Deficiency Due to Two Novel COQ6 Variants.

A Family Segregating Lethal Primary Coenzyme Q10 Deficiency Due to Two Novel COQ6 Variants.

Journal: Frontiers in genetics

Published: November 09, 2021

11p11.12p12 duplication in a family with intellectual disability and craniofacial anomalies.

11p11.12p12 duplication in a family with intellectual disability and craniofacial anomalies.

Journal: BMC medical genomics

Published: August 13, 2020

Sustained activation of C3aR in a human podocyte line impairs the morphological maturation of the cells.

Sustained activation of C3aR in a human podocyte line impairs the morphological maturation of the cells.

Journal: Molecular medicine reports

Published: March 30, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026